Press releases
Regulatory press release 2024-05-08
Interim Report First Quarter 2024
Regulatory press release 2024-05-03
Xspray Pharma raises SEK 100.3 million through warrants TO6
Regulatory press release 2024-04-22
Xspray Pharma Announces Fourth Product Candidate, targeting USD 2.3 billion Market
Regulatory press release 2024-04-19
Xspray Pharma receives declaration of intent from Östersjöstiftelsen regarding exercise of TO6 warrants
Regulatory press release 2024-04-18
Notice of annual general meeting of Xspray Pharma AB (publ)
Regulatory press release 2024-04-10
Xspray Pharma receives declarations of intent from its largest owners regarding exercise of TO6 warrants
Regulatory press release 2024-03-27
Xspray Pharma publishes its Annual Report 2023
Regulatory press release 2024-02-14
Interim Report Fourth Quarter 2023
Regulatory press release 2024-02-12
FDA Accepts Xspray Pharma’s NDA-resubmission for Dasynoc® – PDUFA Date set to 31 July
Regulatory press release 2024-02-07